Gong S - Search Results

1

How Do Patients and Doctors Perceive Medical Services for Rare Diseases Differently in China? Insights from Two National Surveys.

Gong S, Li D, Dong D. Gong S, et al. Int J Environ Res Public Health. 2020 Aug 17;17(16):5961. doi: 10.3390/ijerph17165961. Int J Environ Res Public Health. 2020. PMID: 32824597 Free PMC article.

2

The availability and affordability of orphan drugs for rare diseases in China.

Gong S, Wang Y, Pan X, Zhang L, Huang R, Chen X, Hu J, Xu Y, Jin S. Gong S, et al. Orphanet J Rare Dis. 2016 Feb 27;11:20. doi: 10.1186/s13023-016-0392-4. Orphanet J Rare Dis. 2016. PMID: 26920579 Free PMC article.

3

Why is misdiagnosis more likely among some people with rare diseases than others? Insights from a population-based cross-sectional study in China.

Dong D, Chung RY, Chan RHW, Gong S, Xu RH. Dong D, et al. Among authors: gong s. Orphanet J Rare Dis. 2020 Oct 28;15(1):307. doi: 10.1186/s13023-020-01587-2. Orphanet J Rare Dis. 2020. PMID: 33115515 Free PMC article.

4

Social activity as mediator between social support and psychological quality of life among people with rare diseases: A national repetitive cross-sectional study.

Chen S, Wang Y, Zhu L, Feng Z, Gong S, Dong D. Chen S, et al. Among authors: gong s. J Psychiatr Res. 2022 Jun;150:147-152. doi: 10.1016/j.jpsychires.2022.03.042. Epub 2022 Mar 28. J Psychiatr Res. 2022. PMID: 35378487

5

Is sub-national healthcare social protection sufficient for protecting rare disease patients? the case of China.

Xu J, Yu M, Zhang Z, Gong S, Li B. Xu J, et al. Among authors: gong s. Front Public Health. 2023 Jun 16;11:1198368. doi: 10.3389/fpubh.2023.1198368. eCollection 2023. Front Public Health. 2023. PMID: 37397721 Free PMC article. Review.

6

Current progress in the management of rare diseases and orphan drugs in China.

Gong S, Jin S. Gong S, et al. Intractable Rare Dis Res. 2012 May;1(2):45-52. doi: 10.5582/irdr.2012.v1.2.45. Intractable Rare Dis Res. 2012. PMID: 25343073 Free PMC article. Review.

7

Impact of universal medical insurance system on the accessibility of medical service supply and affordability of patients in China.

Xiong X, Zhang Z, Ren J, Zhang J, Pan X, Zhang L, Gong S, Jin S. Xiong X, et al. Among authors: gong s. PLoS One. 2018 Mar 7;13(3):e0193273. doi: 10.1371/journal.pone.0193273. eCollection 2018. PLoS One. 2018. PMID: 29513712 Free PMC article.

8

The availability, price and affordability of antidiabetic drugs in Hubei province, China.

Gong S, Cai H, Ding Y, Li W, Juan X, Peng J, Jin S. Gong S, et al. Health Policy Plan. 2018 Oct 1;33(8):937-947. doi: 10.1093/heapol/czy076. Health Policy Plan. 2018. PMID: 30215707

9

The availability, price and affordability of essential antibacterials in Hubei province, China.

Wu G, Gong S, Cai H, Ding Y. Wu G, et al. Among authors: gong s. BMC Health Serv Res. 2018 Dec 29;18(1):1013. doi: 10.1186/s12913-018-3835-x. BMC Health Serv Res. 2018. PMID: 30594189 Free PMC article.

10

Perceptions of Generic Drugs in the Pharmacists of Public Hospitals: A Cross-sectional Survey in Hubei Province of China.

Li WJ, Xia MJ, Gong SW, Ding YF. Li WJ, et al. Curr Med Sci. 2021 Oct;41(5):987-995. doi: 10.1007/s11596-021-2412-4. Epub 2021 Sep 2. Curr Med Sci. 2021. PMID: 34476663

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

4,023 results

Search Page

Filters